Agios Pharmaceuticals

About:

Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.

Website: https://www.agios.com

Twitter/X: agiospharma

Top Investors: Flagship Pioneering, Third Rock Ventures, ARCH Venture Partners, Celgene

Description:

Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.

Total Funding Amount:

$776M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)agios.com

Founders:

Craig Thompson, Lewis C. Cantley, Shin-San Michael Su, Tak Mak

Number of Employees:

101-250

Last Funding Date:

2019-11-07

IPO Status:

Public

© 2025 bioDAO.ai